Health and Fitness Health and Fitness
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Ligand to Present at the Citi Global Health Care Conference on February 28th
[ Tue, Feb 21st 2012 ] - Market Wire
Mylan Secures an Additional $300 Million of Committed Financing
[ Tue, Feb 21st 2012 ] - Market Wire
Natus to Present at Citi 2012 Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
A Phase 3 Study to Assess Repeat Treatment Effica .. 0MG TID in Subjects with Irritable Bowel Syndrome
[ Tue, Feb 21st 2012 ] - Market Wire
Hospira Works With FDA to Help Avert Methotrexate .. One Month's Supply of New Product Immediately and
[ Tue, Feb 21st 2012 ] - Market Wire
Community Health Systems, Inc. to Participate in Two Investor Conferences in February
[ Tue, Feb 21st 2012 ] - Market Wire
American Oriental Bioengineering Inc. Announces Plans for Reverse Stock Split of its Common Stock
[ Tue, Feb 21st 2012 ] - Market Wire
Quest Diagnostics Offers Industry-First 30-Day Am .. R Implementation Guarantee for Hospitals and IDNs
[ Tue, Feb 21st 2012 ] - Market Wire
MIT Receives First ARRONAX Shipment, Launching Strontium-82 Validation Project
[ Tue, Feb 21st 2012 ] - Market Wire
BRILINTA (ticagrelor) Added to American College o .. tions on Antithrombotic Therapy and Prevention of
[ Tue, Feb 21st 2012 ] - Market Wire
IGSM Group INC. Lays the Foundation for the Master Plan of a Holding Company
[ Tue, Feb 21st 2012 ] - Market Wire
ImmunoCellular, Willis Group Holdings, Encana, Exxon Mobil and Cenovus Energy
[ Tue, Feb 21st 2012 ] - Market Wire
Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Gilead Sciences, Chesapeake Energy, Wells Fargo, Applied Materials, and Pfizer
[ Tue, Feb 21st 2012 ] - Market Wire
Telik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies
[ Tue, Feb 21st 2012 ] - Market Wire
Peter A. Marmerstein Appointed President of West Florida Division
[ Tue, Feb 21st 2012 ] - Market Wire
Boston Scientific, Alcoa, Alcatel-Lucent, Atmel, and Delta Air Lines
[ Tue, Feb 21st 2012 ] - Market Wire
Enzo Biochem Receives Approval for Novel Blood Based Test for Colorectal Cancer Risk
[ Tue, Feb 21st 2012 ] - Market Wire
Dehaier Medical Retains The Equity Group to Provide Investor Relations Services
[ Tue, Feb 21st 2012 ] - Market Wire
Genomma Lab Internacional Announces Non-binding P .. tige Brands Holdings for $16.60 Per Share in Cash
[ Tue, Feb 21st 2012 ] - Market Wire
Paladin Announces Strategic Partnership with Lith .. erging of South African Pharmaceutical Businesses
[ Tue, Feb 21st 2012 ] - Market Wire
EnteroMedics to Participate in 4th Annual Lazard Capital Markets Medical Technology Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Theratechnologies Announces a Supply, Distributio .. ng Agreement With Actelion Pharmaceuticals Canada
[ Tue, Feb 21st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers
[ Tue, Feb 21st 2012 ] - Market Wire
Horizon Pharma to Present at the Cowen and Company Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Response Genetics Regains NASDAQ Compliance
[ Tue, Feb 21st 2012 ] - Market Wire
Repligen Announces FDA Grant of Priority Review for SecreFloa" NDA
[ Tue, Feb 21st 2012 ] - Market Wire
China Cord Blood Corporation to Report Third Quar .. irst Nine Months of Fiscal 2012 Financial Results
[ Tue, Feb 21st 2012 ] - Market Wire
Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference

Salix Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference


Published on 2012-02-21 04:20:11 - Market Wire
  Print publication without navigation


RALEIGH, N.C.--([ ])--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the 2012 RBC Capital Markets Healthcare Conference in New York, NY on Tuesday, February 28, 2012 at 2:35 p.m. ET.

Interested parties can access a live audio web cast of the presentation at [ http://www.salix.com ]. A replay of the presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salixas strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Companyas gastroenterology specialty sales and marketing team.

Salix trades on the NASDAQ Global Select Market under the ticker symbol aSLXPa.

For more information, please visit our Website at [ www.salix.com ] or contact the Company at 919-862-1000. Follow us on Twitter (@SalixPharma) and Facebook ([ www.facebook.com/SalixPharma ]). Information on our web site is not incorporated in our SEC filings.

Contributing Sources